Arrivent Biopharma, Common Stock Price History

AVBP Stock   27.45  0.86  3.23%   
If you're considering investing in ArriVent Stock, it is important to understand the factors that can impact its price. As of today, the current price of ArriVent BioPharma, stands at 27.45, as last reported on the 25th of November, with the highest price reaching 27.64 and the lowest price hitting 25.65 during the day. Currently, ArriVent BioPharma, Common is not too volatile. ArriVent BioPharma, secures Sharpe Ratio (or Efficiency) of 0.0142, which signifies that the company had a 0.0142% return per unit of risk over the last 3 months. We have found thirty technical indicators for ArriVent BioPharma, Common, which you can use to evaluate the volatility of the firm. Please confirm ArriVent BioPharma,'s Mean Deviation of 2.85, risk adjusted performance of 0.0642, and Downside Deviation of 4.08 to double-check if the risk estimate we provide is consistent with the expected return of 0.0522%.
  
As of 11/25/2024, Stock Based Compensation is likely to grow to about 1.1 M, while Total Stockholder Equity is likely to drop slightly above 134.6 M. . As of 11/25/2024, Price Earnings Ratio is likely to drop to -9.68. In addition to that, Price Book Value Ratio is likely to drop to 4.01. ArriVent Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0142

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskAVBPHuge Risk
Negative Returns

Estimated Market Risk

 3.68
  actual daily
32
68% of assets are more volatile

Expected Return

 0.05
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.01
  actual daily
1
99% of assets perform better
Based on monthly moving average ArriVent BioPharma, is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ArriVent BioPharma, by adding it to a well-diversified portfolio.
Price Book
2.69
Book Value
8.853
Enterprise Value
499.6 M
Shares Float
16.7 M
Shares Outstanding
33.6 M

ArriVent BioPharma, Stock Price History Chart

There are several ways to analyze ArriVent Stock price data. The simplest method is using a basic ArriVent candlestick price chart, which shows ArriVent BioPharma, price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 7, 202435.63
Lowest PriceSeptember 23, 202422.64

ArriVent BioPharma, November 25, 2024 Stock Price Synopsis

Various analyses of ArriVent BioPharma,'s daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell ArriVent Stock. It can be used to describe the percentage change in the price of ArriVent BioPharma, from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of ArriVent Stock.
ArriVent BioPharma, Price Daily Balance Of Power 0.43 
ArriVent BioPharma, Price Rate Of Daily Change 1.03 
ArriVent BioPharma, Price Action Indicator 1.23 

ArriVent BioPharma, November 25, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in ArriVent Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use ArriVent BioPharma, intraday prices and daily technical indicators to check the level of noise trading in ArriVent Stock and then apply it to test your longer-term investment strategies against ArriVent.

ArriVent Stock Price History Data

The price series of ArriVent BioPharma, for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 has a statistical range of 12.99 with a coefficient of variation of 11.67. The prices are distributed with arithmetic mean of 27.68. The median price for the last 90 days is 27.41.
OpenHighLowCloseVolume
11/25/2024
 26.68  27.64  25.65  27.45 
11/22/2024 26.68  27.64  25.65  27.45  108,061 
11/21/2024 27.56  27.81  26.57  26.59  183,781 
11/20/2024 27.42  28.82  27.27  27.41  96,391 
11/19/2024 27.04  28.04  26.40  27.42  100,941 
11/18/2024 27.18  27.61  26.49  27.05  141,946 
11/15/2024 28.46  28.46  26.77  27.21  293,143 
11/14/2024 31.67  32.01  27.64  28.08  299,878 
11/13/2024 33.44  33.64  31.84  31.86  93,421 
11/12/2024 34.00  34.35  32.68  32.99  90,431 
11/11/2024 34.12  34.92  33.57  34.33  171,833 
11/08/2024 35.87  36.00  33.17  34.19  192,639 
11/07/2024 35.41  36.20  34.51  35.63  183,200 
11/06/2024 33.62  35.97  32.52  34.91  241,200 
11/05/2024 31.43  32.00  31.07  31.98  66,880 
11/04/2024 30.92  32.01  30.42  31.49  108,328 
11/01/2024 29.36  30.78  28.50  30.78  114,500 
10/31/2024 31.65  31.65  29.17  29.34  105,354 
10/30/2024 31.02  32.00  31.02  31.47  59,953 
10/29/2024 31.96  32.19  30.70  31.22  74,372 
10/28/2024 32.07  32.40  31.61  32.17  122,981 
10/25/2024 31.34  32.03  31.04  31.68  167,801 
10/24/2024 30.50  31.76  30.50  31.02  152,411 
10/23/2024 29.78  30.35  29.46  30.24  272,075 
10/22/2024 29.00  30.12  28.51  30.05  190,535 
10/21/2024 29.20  29.20  28.37  28.71  74,471 
10/18/2024 29.00  29.47  28.72  29.16  54,610 
10/17/2024 29.73  29.94  28.74  28.99  77,161 
10/16/2024 28.37  29.81  28.14  29.74  164,035 
10/15/2024 27.76  28.72  27.42  28.41  117,863 
10/14/2024 28.14  28.38  27.79  27.94  81,060 
10/11/2024 27.74  29.10  27.74  28.24  195,200 
10/10/2024 26.98  28.14  26.53  27.79  89,779 
10/09/2024 27.20  28.03  26.57  27.07  106,041 
10/08/2024 27.59  28.48  27.22  27.39  147,308 
10/07/2024 27.16  28.17  27.09  27.45  195,800 
10/04/2024 26.01  27.89  26.01  27.26  250,451 
10/03/2024 23.61  25.77  23.61  25.62  278,759 
10/02/2024 23.75  24.09  23.41  23.79  181,500 
10/01/2024 23.05  24.28  23.00  23.79  191,583 
09/30/2024 23.00  23.50  23.00  23.50  105,281 
09/27/2024 23.66  24.11  22.59  23.00  215,533 
09/26/2024 23.30  24.01  23.11  23.51  122,728 
09/25/2024 23.41  23.71  22.81  23.11  145,600 
09/24/2024 22.62  24.10  22.57  23.56  213,529 
09/23/2024 25.04  25.04  22.39  22.64  452,549 
09/20/2024 24.05  25.46  23.75  24.81  3,143,790 
09/19/2024 23.89  25.14  23.67  24.20  531,551 
09/18/2024 23.22  24.57  23.22  23.59  358,060 
09/17/2024 24.72  25.16  23.87  23.94  248,919 
09/16/2024 23.72  24.86  22.74  24.54  464,617 
09/13/2024 23.80  24.31  22.30  23.76  341,856 
09/12/2024 25.69  25.94  23.76  23.79  264,731 
09/11/2024 27.57  27.74  25.35  25.36  228,181 
09/10/2024 29.26  29.26  27.16  27.29  435,319 
09/09/2024 28.54  30.99  27.17  27.73  862,960 
09/06/2024 26.89  28.24  26.24  28.01  392,300 
09/05/2024 25.60  26.70  25.20  26.60  269,867 
09/04/2024 25.60  26.96  25.59  26.12  235,110 
09/03/2024 26.89  27.04  25.69  26.00  217,480 
08/30/2024 26.35  27.40  26.35  26.73  187,472 

About ArriVent BioPharma, Stock history

ArriVent BioPharma, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ArriVent is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ArriVent BioPharma, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ArriVent BioPharma, stock prices may prove useful in developing a viable investing in ArriVent BioPharma,
Last ReportedProjected for Next Year
Common Stock Shares Outstanding28.8 M26.4 M

ArriVent BioPharma, Quarterly Net Working Capital

296.41 Million

ArriVent BioPharma, Stock Technical Analysis

ArriVent BioPharma, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of ArriVent BioPharma, technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of ArriVent BioPharma, trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Price Ceiling Movement Now

   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
All  Next Launch Module

ArriVent BioPharma, Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for ArriVent BioPharma,'s price direction in advance. Along with the technical and fundamental analysis of ArriVent Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ArriVent to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for ArriVent Stock Analysis

When running ArriVent BioPharma,'s price analysis, check to measure ArriVent BioPharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ArriVent BioPharma, is operating at the current time. Most of ArriVent BioPharma,'s value examination focuses on studying past and present price action to predict the probability of ArriVent BioPharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ArriVent BioPharma,'s price. Additionally, you may evaluate how the addition of ArriVent BioPharma, to your portfolios can decrease your overall portfolio volatility.